NI201000077A - Métodos para cocultivar células derivadas de sangre de cordón umbilical con células madre menstruales. - Google Patents

Métodos para cocultivar células derivadas de sangre de cordón umbilical con células madre menstruales.

Info

Publication number
NI201000077A
NI201000077A NI201000077A NI201000077A NI201000077A NI 201000077 A NI201000077 A NI 201000077A NI 201000077 A NI201000077 A NI 201000077A NI 201000077 A NI201000077 A NI 201000077A NI 201000077 A NI201000077 A NI 201000077A
Authority
NI
Nicaragua
Prior art keywords
cord blood
cells
methods
expanded
umbilical cord
Prior art date
Application number
NI201000077A
Other languages
English (en)
Inventor
A Walton Mercedes
G Allickson Julie
Original Assignee
Cryo Cell Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40591376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI201000077(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cryo Cell Int Inc filed Critical Cryo Cell Int Inc
Publication of NI201000077A publication Critical patent/NI201000077A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1352—Mesenchymal stem cells
    • C12N2502/137—Blood-borne mesenchymal stem cells, e.g. Msc from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1352—Mesenchymal stem cells
    • C12N2502/1388—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/243—Cells of the female genital tract, non-germinal ovarian cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proveen métodos para obtener células expandidas de sangre de cordón umbilical humano que expresan CD34. Los métodos incluyen sembrar una cantidad suficiente de células de sangre de cordón con una cantidad suficiente de células menstruales, en condiciones de cocultivo adecuadas para promover la expansión de las células de sangre de cordón, y cocultivar las células de sangre de cordón con las células menstruales en condiciones de cultivo que soporten, al menos, dos o más duplicaciones de población de células de sangre de cordón. También se proveen métodos para desarrollar células expandidas de sangre de cordón umbilical humano para originar cualquiera de las unidades formadoras de colonias de células precursoras de linaje sanguíneo: unidad formadora de colonia granulocítica y macrofágica (CFU-GM), unidades formadoras de brotes eritroides (BFU-E), y unidad formadora de colonia granulocítica, eritroide, macrofágica, megacariocíticas (CFU-GEMM). Las células expandidas pueden expresar CD34, SSEA-4, y HLA-ll. También se proveen las composiciones de las células expandidas.
NI201000077A 2007-10-31 2010-04-30 Métodos para cocultivar células derivadas de sangre de cordón umbilical con células madre menstruales. NI201000077A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US145607P 2007-10-31 2007-10-31

Publications (1)

Publication Number Publication Date
NI201000077A true NI201000077A (es) 2010-09-07

Family

ID=40591376

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201000077A NI201000077A (es) 2007-10-31 2010-04-30 Métodos para cocultivar células derivadas de sangre de cordón umbilical con células madre menstruales.

Country Status (18)

Country Link
US (2) US20090191628A1 (es)
EP (1) EP2212418A4 (es)
JP (1) JP2011501960A (es)
KR (1) KR20100091192A (es)
CN (1) CN101952416A (es)
AR (1) AR069156A1 (es)
AU (1) AU2008319284A1 (es)
BR (1) BRPI0818152A2 (es)
CA (1) CA2714777A1 (es)
CL (1) CL2008003282A1 (es)
CR (1) CR11409A (es)
EC (1) ECSP10010189A (es)
IL (1) IL205470A0 (es)
MX (1) MX2010004914A (es)
NI (1) NI201000077A (es)
PA (1) PA8802801A1 (es)
TW (1) TW200936148A (es)
WO (1) WO2009058365A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010056988A2 (en) 2008-11-13 2010-05-20 University Of South Florida Methods of treating stroke using stem cell-like menstrual blood cells
DE102011101054A1 (de) 2011-05-09 2012-02-16 Bernhard Hildebrandt Geräte und Vorrichtungen für das Implantationsverfahren für Endoprothesen, welches ein Systemzentrum und eine Systemachse sowie den dazu erforderlichen Gerätekomplex aus Fixiervorrichtung, Extensionsvorrichtung, Gliedmaßenhalterung und Steuergerät als Grundlage hat.
WO2013025189A1 (en) * 2011-08-12 2013-02-21 Cryo-Cell International, Inc. Methods for co-culturing cord blood cells or cord tissue cells with menstrual multipotent cells
KR101348093B1 (ko) * 2012-02-15 2014-01-16 고려대학교 산학협력단 공동 배양된 세포를 포함하는 섬유 및 그 제조방법
US20160024473A1 (en) * 2013-03-08 2016-01-28 Cells For Cells Menstrual stems cells for the efficient support and expansion of cd34+ cd133+ hematopoietic stem cells in vitro
JP6754459B2 (ja) * 2013-08-19 2020-09-09 国立研究開発法人国立循環器病研究センター 羊膜間葉系細胞組成物の製造方法及び凍結保存方法、並びに治療剤
JP6512759B2 (ja) 2013-08-19 2019-05-15 国立研究開発法人国立循環器病研究センター 羊膜間葉系細胞組成物の製造方法及び凍結保存方法、並びに治療剤
WO2015066076A1 (en) * 2013-10-28 2015-05-07 Biocardia, Inc. Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5840580A (en) * 1990-05-01 1998-11-24 Becton Dickinson And Company Phenotypic characterization of the hematopoietic stem cell
US7410773B2 (en) * 1995-02-02 2008-08-12 Ghazi Jaswinder Dhoot Method of preparing an undifferentiated cell
US7560280B2 (en) * 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
JPWO2006078034A1 (ja) * 2005-01-24 2008-06-19 財団法人ヒューマンサイエンス振興財団 心筋細胞への分化能を有する細胞
US20060182724A1 (en) * 2005-02-15 2006-08-17 Riordan Neil H Method for expansion of stem cells
WO2007011088A1 (en) * 2005-07-20 2007-01-25 Seoul National University Industry Foundation Method for culturingand proliferating hematopoietic stem cells and progenitor cells using human endometrial cells
US20080241113A1 (en) * 2007-03-01 2008-10-02 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of endometrial/menstrual cells

Also Published As

Publication number Publication date
ECSP10010189A (es) 2010-06-29
JP2011501960A (ja) 2011-01-20
EP2212418A1 (en) 2010-08-04
CR11409A (es) 2010-08-13
CN101952416A (zh) 2011-01-19
TW200936148A (en) 2009-09-01
EP2212418A4 (en) 2010-12-08
CL2008003282A1 (es) 2010-04-09
BRPI0818152A2 (pt) 2014-10-14
IL205470A0 (en) 2010-12-30
WO2009058365A1 (en) 2009-05-07
MX2010004914A (es) 2010-08-18
KR20100091192A (ko) 2010-08-18
CA2714777A1 (en) 2009-05-07
US20120208275A1 (en) 2012-08-16
AR069156A1 (es) 2009-12-30
PA8802801A1 (es) 2009-06-23
AU2008319284A1 (en) 2009-05-07
US20090191628A1 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
NI201000077A (es) Métodos para cocultivar células derivadas de sangre de cordón umbilical con células madre menstruales.
AR078849A1 (es) Celulas madre multipotenciales del arbol biliar extrahepatico y metodos de aislamiento de las mismas
Harvey et al. Interplay between metabolites and the epigenome in regulating embryonic and adult stem cell potency and maintenance
GB2434157A (en) Platelets from stem cells
UY30796A1 (es) 3-h-pirazolopiridinas y sales de éstas, composiciones farmacéuticas que las comprenden, métodos para prepararlas, y sus usos
BRPI0514387B8 (pt) método para isolar células-tronco epiteliais ou mesenquimais/progenitoras da membrana amniótica do cordão umbilical, método in vitro para cultivar células-tronco mesenquimais/progenitoras, composição farmacêutica e uso de uma célula-tronco epitelial ou mesenquimal/progenitora
WO2007117765A3 (en) Ex vivo generated tissue system
CO6410309A2 (es) Compuestos que expanden las celulas madre hematopoieticas
ES2722930T3 (es) Procedimiento de aislamiento para células madre pluripotentes derivadas de sangre umbilical que expresan ZNF281
CO6470821A2 (es) Pirazinilpirazoles
BR112012030818A2 (pt) "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv"
ES2721180T3 (es) Productos terapéuticos usando células adiposas y secreciones celulares
Shirane et al. Regulation of SIRT1 determines initial step of endometrial receptivity by controlling E-cadherin expression
BR112012018443A8 (pt) métodos para a fabricação das paredes celulares das plantas compreendendo a quitina
AR080816A1 (es) Preparacion derivada de un cultivo in vitro de celulas de argan no evocadas desdiferenciadas, su uso para el tratamiento del envejecimiento, la inflamacion y curacion de la piel, y metodo para su obtencion
CL2011002786A1 (es) Uso de una biomasa derivada de un cultivo de la bacteria metanotrofica en la elaboracion de un agente para la prevencion o la mejoria de la enteritis inducida por las plantas en los peces; componente de alimento que consiste de dicha biomasa y un material de planta; y proceso de preparacion de dicho componente.
WO2010059876A3 (en) In vitro human b lymphopoiesis culture system
UY29434A1 (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como inhibidores de la inflamacinn
BR112015009229A2 (pt) composição tendo como alvo a expressão de genes para plaquetas, célula tronco hematopoiética, uso da referida célula tronco e método in vitro ou ex vivo para gerar uma célula tronco modificada
ATE547110T1 (de) Verwendung von zellen aus fettgewebe zur herstellung eines antitumoralen medikaments
CL2013000893A1 (es) Medio para cultivo de celulas de mamiferos que comprende sobrenadante de la etapa i del fraccionamiento de cohn; procedimiento de preparacion del medio; uso del medio de cultivo para cultivar celulas de mamiferos.
Tatullo et al. Stem cells and regenerative medicine
WO2007137827A8 (de) Isoliertes naturidentisches kollagen
AR120475A1 (es) Producción de células precursoras hematopoyéticas
UY31522A1 (es) Nanoparticulas con superficie modificada